1. ホーム
  2. 英文記事のバックナンバー
  3. National News
  4. 2018.8.10

Kyoto team to test iPS cells on Parkinson’s disease in world firstパーキンソン病治療にiPS、世界初の臨床試験へ

Kyoto University professor Jun Takahashi tells a news conference on July 30 that the university will begin clinical tests using induced pluripotent stem cells to treat Parkinson’s disease.© KYODO
Level

A Kyoto University research team said July 30 it will begin a clinical test using induced pluripotent stem cells to treat Parkinson’s disease, in what will be the world’s first application of iPS technology to the progressive neurological disorder.

The team led by Jun Takahashi, a professor at the university’s Center for iPS Cell Research and Application, has received government approval and is soliciting seven patients to participate in the trial, which will be conducted at Kyoto University Hospital.

The research team said one of the patients taking part in the study will be selected from those being treated at Kyoto University Hospital.

The researchers are aiming to develop the method as a new treatment covered by national health insurance.

While some experts call for careful application due to concerns that iPS cells could turn into malignant tumors, Takahashi said at a news conference the trial could provide patients with a “promising choice of treatment.”(Kyodo)

和訳を見る

バックナンバー一覧へ戻るカテゴリー一覧へ戻る

広告の掲載について 詳しくはこちら

定期購読申込み無料試読申込み

定期購読申込み無料試読申込み